Taken together, the observed switch in isoform usage might imply that regulatory mechanisms of PDE4D-catalyzed cAMP degradation are subjected to AR signalling in PCa cells that, in turn, indicates that PDE4D7-specific protein domains are necessary to regulate cAMP signalling in an androgen-dependent manner, offering a potentially new drug target [15, 16, 18]. The gene discussed is AR; the disease is posterior cortical atrophy.